Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cathepsins: Novel opportunities for antibody therapeutics in cancer.
David T, du Roure PD, Mallavialle A, Laurent-Matha V, Roger P, Guiu S, Chardès T, Liaudet-Coopman E. David T, et al. Among authors: guiu s. Br J Pharmacol. 2025 Jan 21. doi: 10.1111/bph.17437. Online ahead of print. Br J Pharmacol. 2025. PMID: 39834229 Review.
Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features.
Boissière-Michot F, Chateau MC, Thézenas S, Lafont V, Crapez E, Sharma P, Bobrie A, Roger P, Guiu S, Jacot W. Boissière-Michot F, et al. Among authors: guiu s. Front Immunol. 2024 Dec 12;15:1507371. doi: 10.3389/fimmu.2024.1507371. eCollection 2024. Front Immunol. 2024. PMID: 39723208 Free PMC article.
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer.
Massa D, Vernieri C, Nicolè L, Criscitiello C, Boissière-Michot F, Guiu S, Bobrie A, Griguolo G, Miglietta F, Vingiani A, Lobefaro R, Taurelli Salimbeni B, Pinato C, Schiavi F, Brich S, Pescia C, Fusco N, Pruneri G, Fassan M, Curigliano G, Guarneri V, Jacot W, Dieci MV. Massa D, et al. Among authors: guiu s. J Natl Cancer Inst. 2024 Dec 1;116(12):1914-1927. doi: 10.1093/jnci/djae178. J Natl Cancer Inst. 2024. PMID: 39083015 Free PMC article.
Use of resources in elderly patients consulting the emergency department: analysis of the Emergency Department and Elder Needs Cohort (EDEN-21).
Fuentes E, Jacob J, Del Castillo JG, Montero-Pérez FJ, Alquezar-Arbé A, García-Lamberechts EJ, Aguiló S, Fernández-Alonso C, Burillo-Putze G, Piñera P, Llauger L, Vázquez-Rey V, Carrasco-Fernández E, Juárez R, Blanco-Hoffman MJ, de Las Nieves Rodríguez E, Rios-Gallardo R, Berenguer-Diez MA, Guiu S, López-Laguna N, Delgado-Sardina V, Diego-Robledo FJ, Ezponda P, Martínez-Lorenzo A, Ortega-Liarte JV, García-Rupérez I, Borne-Jerez S, Gil-Rodrigo A, Llorens P, Miró Ò; EDEN Research Group. Fuentes E, et al. Among authors: guiu s. Intern Emerg Med. 2024 Jun 19. doi: 10.1007/s11739-024-03638-z. Online ahead of print. Intern Emerg Med. 2024. PMID: 38896167
Tucatinib Combination Treatment After Trastuzumab-Deruxtecan in Patients With ERBB2-Positive Metastatic Breast Cancer.
Frenel JS, Zeghondy J, Guérin-Charbonnel C, Mailliez A, Volant E, Poumeaud F, Patsouris A, Arnedos M, Bailleux C, Cabal J, Galland L, de Nonneville A, Guiu S, Dalenc F, Pistilli B, Bachelot T, Pierga JY, Le Du F, Bocquet F, Larrouquere L, Loirat D. Frenel JS, et al. Among authors: guiu s. JAMA Netw Open. 2024 Apr 1;7(4):e244435. doi: 10.1001/jamanetworkopen.2024.4435. JAMA Netw Open. 2024. PMID: 38568692 Free PMC article.
A novel Fc-engineered cathepsin D-targeting antibody enhances ADCC, triggers tumor-infiltrating NK cell recruitment, and improves treatment with paclitaxel and enzalutamide in triple-negative breast cancer.
Desroys du Roure P, Lajoie L, Mallavialle A, Alcaraz LB, Mansouri H, Fenou L, Garambois V, Rubio L, David T, Coenon L, Boissière-Michot F, Chateau MC, Ngo G, Jarlier M, Villalba M, Martineau P, Laurent-Matha V, Roger P, Guiu S, Chardès T, Gros L, Liaudet-Coopman E. Desroys du Roure P, et al. Among authors: guiu s. J Immunother Cancer. 2024 Jan 30;12(1):e007135. doi: 10.1136/jitc-2023-007135. J Immunother Cancer. 2024. PMID: 38290768 Free PMC article.
82 results